|
Cerebral and Done are known for treating patients with ADHD,
prescribing stimulants such as Adderall.
Walmart confirmed the move to Reuters and said the decision was
made after an audit and compliance process.
CVS said it would not accept prescriptions for controlled
substances issued by the startups effective May 26, as a result
of a review it conducted on the telehealth firms and after it
was "unable to resolve concerns we have with Cerebral and Done
Health."
Cerebral had earlier this month decided to stop prescribing
controlled substances and taper existing prescriptions based on
the impending expiration of waivers, the company said in an
emailed statement.
The company was working to ensure that existing patients with
controlled substance prescriptions are able to receive their
medications, while working with the pharmacies to allow
sufficient time to adjust to the changes, Cerebral said.
The company said it plans to continue to prescribe controlled
substances to treat opioid use disorder.
Done Health did not respond to a request for comment.
According to a Wall Street Journal earlier this month, Cerebral
had been issued a subpoena by federal prosecutors as part of an
investigation into possible violations of the Controlled
Substances Act.
(Reporting by Ananya Mariam Rajesh, Juby Babu and Siddharth
Cavale in Bengaluru; editing by Uttaresh.V and Sriraj Kalluvila)
[© 2022 Thomson Reuters. All rights
reserved.]
This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
